Virus Purification
Virus Purification - Related Videos
03:35
Affinity Chromatography-Based Purification of Adeno-Associated Virus Vectors
0 Views •
2026
Source: Rghei, A. D., et al. Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models. J. Vis. Exp. (2021)The video demonstrates purification of recombinant adeno-associated virus (AAV) vectors from crude host lysate using a heparin-based affinity matrix. Viral particles bind to immobilized heparin, while impurities are washed away. A high-salt buffer releases intact viruses, which is collected in enriched fractions. These fractions are...
05:02
Purification of Virus from the Allantoic Fluid of Embryonated Chicken Eggs
0 Views •
2026
Source: Yates, J. G. E., et al. Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid. J. Vis. Exp. (2022)The video demonstrates the purification and concentration of virus particles from clarified allantoic fluid collected from virus-infected embryonated chicken eggs. It showcases a series of filtration and separation steps, including depth filtration, tangential flow filtration, and density gradient ultracentrifugation to isolate intact viruses. The virus-rich...
06:17
Expression and Purification of Virus-like Particles for Vaccination
0 Views •
Cited by 27 •
2016
Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible manner.
03:09
Isolation and Purification of Viruses from Infected Insect Bodies
0 Views •
2026
Source: Biesbrock, A. M. et al. Propagation of Homalodisca coagulata virus-01 via Homalodisca vitripennis Cell Culture. J. Vis. Exp. (2014)This video demonstrates the in vitro propagation of Homalodisca coagulata Virus-01 using insect-derived host cells. It outlines the steps for virus purification, inoculation, and replication within cultured insect cells.
03:02
Oncolytic Virus Purification from Infected Mammalian Cells
0 Views •
2026
Source: Nguyen, H., et al. Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus. J. Vis. Exp. (2021)This video demonstrates the purification of an oncolytic virus from infected mammalian cell cultures using nuclease treatment, sequential centrifugation, membrane filtration, and sucrose cushion centrifugation.
FAQs
Clarification reduces the starting mixture’s cellular material and debris before a more selective separation step. This matters because later filtration, ultracentrifugation, or chromatography can then act on a less complex preparation. In a Virus Purification workflow, effective clarification supports cleaner downstream processing and helps produce a preparation whose concentration and biological properties can be assessed more consistently.
The separation method exploits a measurable property of the virion or surrounding material. Filtration distinguishes primarily by size, ultracentrifugation by density, and chromatography by charge or binding behavior. Because these approaches rely on different characteristics, combining them can address different sources of contamination and improve the cleanliness of the final preparation without relying on one separation principle alone.
Purity alone is not sufficient; a preparation may also need to retain infectivity or structural integrity. These attributes determine whether the material remains suitable for medical and research uses, including antiviral testing or viral characterization. Accordingly, purification conditions and the resulting product must be evaluated not only for removal of unwanted material, but also for preserved biological activity or particle structure.
A typical workflow begins with clarification to remove cells and debris, followed by one or more selective operations such as filtration, ultracentrifugation, or chromatography. The sequence concentrates and cleans the virus preparation while separating particles according to relevant properties. At the end, assessment of purity, concentration, sterility, and biological activity helps determine whether the preparation is fit for its intended use.
Post-process assessment should address purity, concentration, sterility, and biological activity. These measures provide complementary information: purity indicates how much unwanted material remains, concentration indicates the amount of virus preparation obtained, sterility addresses product suitability, and biological activity indicates whether function has been retained. Together, they support reproducible experiments and quality assessment in medical and research settings.
Purified preparations provide material for vaccine manufacture, where controlled purity, concentration, sterility, and biological activity support product assessment. The same quality dimensions help make medical production more reproducible and support safety evaluation. Purification therefore contributes not only to obtaining virus particles, but also to controlling the attributes that influence consistency and quality in vaccine-related work.
In research, purified virus supports diagnostic assay development, antiviral testing, and characterization of viral structure and function. Each application may emphasize a different outcome: reliable assay material, a preparation suitable for evaluating antiviral effects, or particles clean enough for structural and functional study. Maintaining appropriate concentration and biological activity helps researchers interpret results with greater confidence.